Medial temporal lobe hyperconnectivity is key to Alzheimer's disease: Insight from physiological aging to dementia
Chauveau, L.; Landeau, B.; Dautricourt, S.; Turpin, A.-L.; Delarue, M.; Hebert, O.; de La Sayette, V.; Chetelat, G.; de Flores, R.
Show abstract
Curing Alzheimers disease (AD) remains hampered by an incomplete understanding of its pathophysiology and progression. Dysfunction within medial temporal lobe networks may provide key insights, as AD proteins seem to propagate specifically through the anterior-temporal (AT) and posterior-medial (PM) systems. Using monocentric longitudinal data from 267 participants spanning physiological aging to the full AD continuum, we found that advancing age was associated with decreased PM connectivity and increased AT connectivity over adult life. When specifically assessing AD-relevant connectivity changes, all AD-associated clinicopathological features, including elevated amyloid burden, AD-typical glucose hypometabolism, hippocampal atrophy, greater cognitive impairment and faster progression from MCI to AD-dementia, were consistently linked to AT hyperconnectivity in healthy to AD-demented older adults. Our comprehensive approach allowed us to reveal that excessive connectivity within the AT network is a pivotal mechanism catalysing pathological process and progression of AD. Such findings hold promise for early diagnosis and therapeutic strategies targeting these specific network alterations.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Differential effects of aging, Alzheimer's pathology, and APOE4 on longitudinal functional connectivity and episodic memory in older adults 98%
- Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer’s disease 97%
- Tau-PET and in vivo Braak-staging as a prognostic marker in Alzheimer’s disease 96%
Similar papers in this journal
- Hemispheric Asymmetry of Tau Pathology is Related to Asymmetric Amyloid Deposition in Alzheimer's Disease 98%
- Amyloid-associated increases in soluble tau is a key driver in accumulation of tau aggregates and cognitive decline in early Alzheimer 97%
- Cognitive Reserve Against Alzheimer's Pathology Is Linked to Brain Activity During Memory Formation 97%